Nortriptyline is a secondary-amine tricyclic antidepressant and the active metabolite of amitriptyline, inhibiting norepinephrine and serotonin reuptake with a comparatively better-tolerated side-effect profile, and is also used for chronic neuropathic pain. Simson Pharma's Nortriptyline reference standard and impurities support compendial testing for this established TCA.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Nortriptyline Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.